Manikanttha Matta, Deepti Kolli, Tej Mandava Bhuvan, Tej Mandava Bhagya, Gopi Reddy A, Kapavarapu Ravikumar, Barange Deepak Kumar, V Basaveswara Rao M, Pal Manojit
Department of Chemistry, Koneru Lakshmaiah Education Foundation, Greenfields, Vaddeswaram, Guntur, Andhra Pradesh 522 502, India.
Department of Healthcare informatics, Sacred Heart University, 5151 Park Avenue, Fair fields, Connecticut CT06825, USA.
J Mol Struct. 2023 May 15;1280:135044. doi: 10.1016/j.molstruc.2023.135044. Epub 2023 Jan 28.
The evaluation of 11-pyrido[2,1-]quinazolin-11-one derivatives against SARS-CoV-2 RdRp was undertaken based on the reports on antiviral activities of this class of compounds in addition to the promising interactions of the antiviral drug penciclovir as well as quinazoline derivatives with SARS-CoV-2 RdRp . The target compounds were prepared an Ullmann-Goldberg type coupling followed by the subsequent cyclization (involving amidation) in a single pot. The methodology involved a CuI-catalyzed reaction of 2-iodobenzoate ester with 2-aminopyridine or quinolin-2-amine or thiazol-2-amine under ultrasound to give the expected products in acceptable (51-93%) yields. The molecular interactions of the synthesized 11-pyrido[2,1-]quinazolin-11-one derivatives with the SARS-CoV-2 RdRp (PDB: 7AAP) were evaluated . The study suggested that though none of these compounds showed interactions better than penciclovir but the compound and appeared to be comparable along with seemed to be nearly comparable to favipiravir and remdesivir. The compound with the best binding energy (-79.85 Kcal/mol) participated in the H-bond interactions through its OMe group with THR556 as well as ARG624 and the N-5 atom with the residue SER682. The studies further suggested that majority of the compounds interacted with the main cavity of active site pocket whereas and that showed relatively lower binding energies (-66.06 and -66.28 Kcal/mol) interacted with the shallow cavity underneath the active site of SARS CoV-2 RdRp. The study also revealed that a OMe group was favourable for interaction with respect to its position in the order C-8 > C-1 > C-2. Further, the presence of a fused quinoline ring was tolerated whereas a fused thiazole ring decreased the interaction significantly. The predictions of pharmacokinetic properties of and indicated that besides the BBB (Blood Brain Barrier) penetration potential these molecules may show a good overall ADME. Overall, the regioisomers and have emerged as molecules of possible interest in the context of targeting COVID-19.
基于此类化合物抗病毒活性的报道,以及抗病毒药物喷昔洛韦和喹唑啉衍生物与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)RNA依赖性RNA聚合酶(RdRp)之间有前景的相互作用,对11-吡啶并[2,1-]喹唑啉-11-酮衍生物抗SARS-CoV-2 RdRp进行了评估。目标化合物通过乌尔曼-戈德堡型偶联反应制备,随后在单锅中进行环化(涉及酰胺化)。该方法涉及在超声条件下,用碘化亚铜催化2-碘苯甲酸酯与2-氨基吡啶、喹啉-2-胺或噻唑-2-胺反应,以可接受的产率(51%-93%)得到预期产物。评估了合成的11-吡啶并[2,1-]喹唑啉-11-酮衍生物与SARS-CoV-2 RdRp(蛋白质数据银行编号:7AAP)的分子相互作用。研究表明,虽然这些化合物均未显示出比喷昔洛韦更好的相互作用,但化合物 和 似乎具有可比性,并且 似乎与法匹拉韦和瑞德西韦几乎具有可比性。具有最佳结合能(-79.85千卡/摩尔)的化合物 通过其甲氧基与苏氨酸556(THR556)以及精氨酸624(ARG624)参与氢键相互作用,并且通过其N-5原子与丝氨酸682(SER682)残基相互作用。 研究进一步表明,大多数化合物与活性位点口袋的主腔相互作用,而 和 显示出相对较低的结合能(-66.06和-66.28千卡/摩尔),它们与SARS-CoV-2 RdRp活性位点下方的浅腔相互作用。该研究还表明,甲氧基在其位置上按C-8 > C-1 > C-2的顺序有利于相互作用。此外,稠合喹啉环的存在是可接受的,而稠合噻唑环会显著降低相互作用。 和 的药代动力学性质预测表明,除了血脑屏障穿透潜力外,这些分子可能具有良好的整体药物代谢动力学性质。总体而言,区域异构体 和 在靶向2019冠状病毒病(COVID-19)方面已成为可能令人感兴趣的分子。